Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study

Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study

Rational: Circulating tumor cells (CTCs) appear to be a promising tool for predicting the clinical outcome and monitoring the response to treatment in patients with solid tumors. The current study assessed the clinical relevance of monitoring CTCs in patients with metastatic castration resistant pro...

Full description

Bibliographic Details
Main Authors: Filippos Koinis, Zafeiris Zafeiriou, Ippokratis Messaritakis, Panagiotis Katsaounis, Anna Koumarianou, Emmanouil Kontopodis, Evangelia Chantzara, Chrissovalantis Aidarinis, Alexandros Lazarou, George Christodoulopoulos, Christos Emmanouilides, Dora Hatzidaki, Galatea Kallergi, Vassilis Georgoulias, Athanasios Kotsakis
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Cancers
Subjects:
cabazitaxel
CTCs
prognostic
prostate cancer
liquid biopsy
CRPC
Online Access:https://www.mdpi.com/2072-6694/15/18/4511

Internet

https://www.mdpi.com/2072-6694/15/18/4511

Similar Items